Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Forskare undersökte syrapumpshämmare med datorsimuleringar – gör koppling till demens

Forskare från Karolinska institutet har i en preklinisk studie sett en mekanism som de anser pekar på att långvarig användning av syradämpande läkemedel kan bidra till en ökad risk för demens.

Hoppfull studie om vaccin mot enterovirus och diabetes

Forskare vid bland annat Karolinska institutet har i studier på möss tagit fram ett vaccin mot virusinfektion som tros kan leda till diabetes typ 1.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Nya datum för spännande event

The Future of Swedish & Danish Life Science och New Updates in Drug Formulation & Bioavailability flyttas fram till september.

Pilots want to live too

Krönika: Collaboration across borders

Drug development creates new challenges for regulators

AI hittar ny antibiotika

Tidigare diabeteskandidat uppvisar lovande egenskaper – Hittades av maskininlärningsalgoritm.

Swedish and Danish Life Science – are there still untapped synergies?

With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish governments, the timing of The Future of Swedish & Danish Life Science conference could not be better. A one-day conference on ongoing collaborations, new directions and required future investment will held on April 2nd at Medicon Village in Lund.

Upcoming event: New updates on drugs

At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and research could become a reality. Kajsa M Paulsson is the project leader for HALOS, driving the idea forward.

”Vi har förberett oss i ett och ett halvt år”

Skåne universitetssjukhus är först i Norden med att testa genterapi mot blödarsjuka.

Ett steg närmare människa på chip

En kombination av åtta olika organ på chip ger en tillförlitlig bild av hur läkemedel kommer att tas upp av den mänskliga kroppen, visar nya studier.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life science village is home to over 150 organisations, employing more than 2,200 people.

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometimes referred to as precision medicine. Gene- and cell therapies have reached the market, exemplified by CAR-T cells, and the research pipeline is promising. In addition, the medical device field is constantly growing creating new solutions to address patient needs.

Astra satsar en miljard dollar på minskade utsläpp

Astrazeneca satsar en 1 miljard dollar på att eliminera koldioxidutsläppen från den globala verksamheten till 2025 och säkerställa att hela värdekedjan är koldioxidnegativ till 2030.

Överväger parallellnotering

" Vår huvudsakliga kommersiella marknad kommer att vara USA" – Calliditas kikar på amerikanska börsen.

17 nätdroger narkotikaklassas

Vissa har orsakat dödsfall.

Spago väljer huvudkandidat

Utvecklar nanopartiklar för tumörselektiv strålning – Nästa steg är proof of concept.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards an exit early 2020.